Boehringer Ingelheim Pharmaceuticals, Inc. is recalling 45,008 units of SPIRIVA HandiHaler (tiotropium bromide inhalation powder) 18 mcg/capsule due to the product failing stability specifications. This medication, used for respiratory conditions, was distributed nationwide in boxes containing 90 capsules (unit dose blisters). Consumers should be aware that the medication may not perform as intended through its listed expiration date. You should contact your doctor or pharmacist to discuss continuing your treatment and obtaining a replacement if your medication is affected.
The product failed stability testing, which means the medication may lose its effectiveness or change in chemical composition before its expiration date, potentially leading to poorly controlled respiratory symptoms. No specific injuries have been reported at the time of this recall.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.